LGALS9 and nasopharyngeal carcinoma: In NPC patients, we observed that Gal-9 was abundant in the tumor cells by comparison with the surrounding non-tumor tissue and in the serum by comparison with serum samples from healthy individuals (Fig. 6a, b).